instruction stringlengths 158 1.42k | input stringlengths 33 966 | response stringclasses 6 values |
|---|---|---|
<Instruct>: Given the context 'Naloxone reverses the antihypertensive effect of clonidine.', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: naltrexone
B: n-allylnoretorphine (aka alletorphine)
C: nalorphine epoxide (aka nalorphine-7,8-oxide)
D: naloxone methiodide (aka n-methylnaloxone)
E: naloxon curamed (aka naloxone)
F: None of the above. | E |
<Instruct>: Given the context 'Naloxone reverses the antihypertensive effect of clonidine.', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: hydrochloride, clonidine (aka clonidine)
B: nitroclofene
C: clonidine-displacing substance
D: clonixin
E: chlornitrofen (aka 2,4,6-trichlorophenyl 4-nitrophenyl ether)
F: None of the above. | A |
<Instruct>: Given the context 'In unanesthetized, spontaneously hypertensive rats the decrease in blood pressure and heart rate produced by intravenous clonidine, 5 to 20 micrograms/kg, was inhibited or reversed by nalozone, 0.2 to 2 mg/kg.', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: clont (aka metronidazole)
B: clonixin
C: (4-chlorophenyl)-(1h-imidazol-4-ylmethyl)-isopropyl-amine
D: clonidine para-isothiocyanate (aka clonidine 4-isothiocyanate)
E: monohydrochloride, clonidine (aka clonidine)
F: None of the above. | E |
<Instruct>: Given the context 'The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone.', select the correct biomedical concept corresponding to 'alpha-methyldopa'. Answer using one of the provided options. | <Options>: A: alpha methyldopa (aka methyldopa)
B: alpha-methyldopamine, (+-)-isomer (aka alpha-methyldopamine)
C: 3-o-methyl-methyldopa (aka 3-o-methylmethyldopa)
D: 3-o-methyl-alpha-methyldopamine
E: 3-o-methyldopa (aka 3-methoxytyrosine)
F: None of the above. | A |
<Instruct>: Given the context 'The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone.', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: allylnormorphine (aka nalorphine)
B: naloxone hydrochloride (aka naloxone)
C: naled
D: naltrexone
E: nalorphine epoxide (aka nalorphine-7,8-oxide)
F: None of the above. | B |
<Instruct>: Given the context 'Naloxone alone did not affect either blood pressure or heart rate.', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: naled
B: naltrexone
C: n-allylnoretorphine (aka alletorphine)
D: naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer (aka naloxone)
E: naloxone methiodide (aka n-methylnaloxone)
F: None of the above. | D |
<Instruct>: Given the context 'In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-5) M, did not influence stereoselective binding of [3H]-naloxone (8 nM), and naloxone, 10(-8) to 10(-4) M, did not influence clonidine-suppressible binding of [3H]-dihydroergocryptine (1 nM).', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: (4-chlorophenyl)-(1h-imidazol-4-ylmethyl)-isopropyl-amine
B: clonidine para-isothiocyanate (aka clonidine 4-isothiocyanate)
C: nitroclofene
D: clonidine-displacing substance
E: clonidine
F: None of the above. | E |
<Instruct>: Given the context 'In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-5) M, did not influence stereoselective binding of [3H]-naloxone (8 nM), and naloxone, 10(-8) to 10(-4) M, did not influence clonidine-suppressible binding of [3H]-dihydroergocryptine (1 nM).', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: nalorphine epoxide (aka nalorphine-7,8-oxide)
B: n-allylnoretorphine (aka alletorphine)
C: naloxone methiodide (aka n-methylnaloxone)
D: naloxone, buprenorphine (aka buprenorphine, naloxone drug combination)
E: naloxone hydrochloride dihydride (aka naloxone)
F: None of the above. | E |
<Instruct>: Given the context 'In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-5) M, did not influence stereoselective binding of [3H]-naloxone (8 nM), and naloxone, 10(-8) to 10(-4) M, did not influence clonidine-suppressible binding of [3H]-dihydroergocryptine (1 nM).', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: clonidine para-isothiocyanate (aka clonidine 4-isothiocyanate)
B: (4-chlorophenyl)-(1h-imidazol-4-ylmethyl)-isopropyl-amine
C: nitroclofene
D: chlornitrofen (aka 2,4,6-trichlorophenyl 4-nitrophenyl ether)
E: 1h-imidazol-2-amine, n-(2,6-dichlorophenyl)-4,5-dihydro- (aka clonidine)
F: None of the above. | E |
<Instruct>: Given the context 'As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: naltrexone
B: nalorphine epoxide (aka nalorphine-7,8-oxide)
C: naloxone, buprenorphine (aka buprenorphine, naloxone drug combination)
D: naled
E: dihydride, naloxone hydrochloride (aka naloxone)
F: None of the above. | E |
<Instruct>: Given the context 'As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.', select the correct biomedical concept corresponding to 'naloxone'. Answer using one of the provided options. | <Options>: A: naled
B: nalorphine epoxide (aka nalorphine-7,8-oxide)
C: buprenorphine naloxone (aka buprenorphine, naloxone drug combination)
D: naltrexone
E: n-allylnoretorphine (aka alletorphine)
F: None of the above. | F |
<Instruct>: Given the context 'As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: (4-chlorophenyl)-(1h-imidazol-4-ylmethyl)-isopropyl-amine
B: clonidine para-isothiocyanate (aka clonidine 4-isothiocyanate)
C: clonitralide (aka niclosamide)
D: nitroclofene
E: clonidine monohydrochloride (aka clonidine)
F: None of the above. | E |
<Instruct>: Given the context 'As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.', select the correct biomedical concept corresponding to 'clonidine'. Answer using one of the provided options. | <Options>: A: chlornitrofen (aka 2,4,6-trichlorophenyl 4-nitrophenyl ether)
B: clonixin
C: clont (aka metronidazole)
D: clonidine-displacing substance
E: 1h-imidazol-2-amine, n-(2,6-dichlorophenyl)-4,5-dihydro- (aka clonidine)
F: None of the above. | E |
<Instruct>: Given the context 'As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.', select the correct biomedical concept corresponding to 'alpha-methyldopa'. Answer using one of the provided options. | <Options>: A: methyldopamine (aka deoxyepinephrine)
B: 3-o-methyldopa (aka 3-methoxytyrosine)
C: 3-o-methyl-alpha-methyldopamine
D: 3-o-methyl-methyldopa (aka 3-o-methylmethyldopa)
E: alpha methyl l dopa (aka methyldopa)
F: None of the above. | E |
<Instruct>: Given the context 'Lidocaine-induced cardiac asystole.', select the correct biomedical concept corresponding to 'lidocaine'. Answer using one of the provided options. | <Options>: A: methyl lidocaine (aka n-methyllidocaine)
B: acetamide, 2-(diethylamino)-n-(2,4,6-trimethylphenyl)- (aka trimecaine)
C: lidol (aka meperidine)
D: lidemol (aka fluocinonide)
E: xylocaine (aka lidocaine)
F: None of the above. | E |
<Instruct>: Given the context 'Intravenous administration of a single 50-mg bolus of lidocaine in a 67-year-old man resulted in profound depression of the activity of the sinoatrial and atrioventricular nodal pacemakers.', select the correct biomedical concept corresponding to 'lidocaine'. Answer using one of the provided options. | <Options>: A: lidol (aka meperidine)
B: lidocaine carbonate (aka lidocaine)
C: lida
D: leocaine
E: methyl lidocaine (aka n-methyllidocaine)
F: None of the above. | B |
<Instruct>: Given the context 'The patient had no apparent associated conditions which might have predisposed him to the development of bradyarrhythmias; and, thus, this probably represented a true idiosyncrasy to lidocaine.', select the correct biomedical concept corresponding to 'lidocaine'. Answer using one of the provided options. | <Options>: A: leocaine
B: 2-2etn-2mephacn (aka lidocaine)
C: methyl lidocaine (aka n-methyllidocaine)
D: lidol (aka meperidine)
E: acetamide, 2-(diethylamino)-n-(2,4,6-trimethylphenyl)- (aka trimecaine)
F: None of the above. | B |
<Instruct>: Given the context 'Suxamethonium infusion rate and observed fasciculations.', select the correct biomedical concept corresponding to 'suxamethonium'. Answer using one of the provided options. | <Options>: A: suxibuzone
B: bromide, suxamethonium (aka succinylcholine)
C: n,n-diethyl-2-((2-methoxy-5-(methylsulfonyl)benzoyl)amino)ethanaminium chloride (aka tiapride hydrochloride)
D: methylmethionine sulfonium chloride (aka vitamin u)
E: suxethonium
F: None of the above. | B |
<Instruct>: Given the context 'Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg s-1 to 20 mg s-1.', select the correct biomedical concept corresponding to 'suxamethonium chloride'. Answer using one of the provided options. | <Options>: A: chloride, methylmethioninesulfonium (aka vitamin u)
B: succinylcholine dichloride (aka succinylcholine)
C: trimethylsulfonium chloride (aka trimethylsulfonium)
D: suxethonium
E: trimethylselenonium chloride (aka trimethylselenonium)
F: None of the above. | B |
<Instruct>: Given the context 'Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg s-1 to 20 mg s-1.', select the correct biomedical concept corresponding to 'sch'. Answer using one of the provided options. | <Options>: A: sch-1000 (aka ipratropium)
B: schmitterite
C: sch-p (aka stilbazochrome-p)
D: schottenol (aka stigmast-7-enol)
E: sch.036 (aka sch 036)
F: None of the above. | F |
<Instruct>: Given the context 'The infusion was discontinued either when there was no muscular response to tetanic stimulation of the ulnar nerve or when Sch 120 mg was exceeded.', select the correct biomedical concept corresponding to 'sch'. Answer using one of the provided options. | <Options>: A: schumannificine
B: schoenoside
C: schoberine
D: sch6
E: schinol (aka masticadienolic acid)
F: None of the above. | F |
<Instruct>: Given the context 'The infusion was discontinued either when there was no muscular response to tetanic stimulation of the ulnar nerve or when Sch 120 mg was exceeded.', select the correct biomedical concept corresponding to 'sch'. Answer using one of the provided options. | <Options>: A: sch-1000 (aka ipratropium)
B: schisanhenol
C: schmitterite
D: schisanartane
E: scholzite
F: None of the above. | F |
<Instruct>: Given the context 'Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).', select the correct biomedical concept corresponding to 'galanthamine hydrobromide'. Answer using one of the provided options. | <Options>: A: galanthamine hydrobromide (aka galantamine)
B: nigeglanine hydrobromide (aka nigeglanine)
C: alentamol hydrobromide, (-)-isomer (aka alentamol)
D: phenacylamine hydrobromide (aka phenacylamine)
E: glycine amide hydrobromide (aka glycine amide)
F: None of the above. | A |
<Instruct>: Given the context 'Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).', select the correct biomedical concept corresponding to 'scopolamine'. Answer using one of the provided options. | <Options>: A: hyoscine n-oxide
B: scopolamine
C: scopolamine derivatives
D: diacetyl scopadol (aka diacetylscopadol)
E: scopadulin
F: None of the above. | B |
<Instruct>: Given the context 'Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).', select the correct biomedical concept corresponding to 'hyoscine'. Answer using one of the provided options. | <Options>: A: scopoderm tts (aka scopolamine)
B: scopolamines (aka scopolamine derivatives)
C: epimeloscine (aka meloscine)
D: hyoscine methiodide (aka n-methylscopolamine)
E: hyoscine n-butylbromide (aka butylscopolammonium bromide)
F: None of the above. | A |
<Instruct>: Given the context 'Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage.', select the correct biomedical concept corresponding to 'galanthamine hydrobromide'. Answer using one of the provided options. | <Options>: A: aniline hydrobromide (aka aniline)
B: diaminoguanidine hydrobromide (aka diaminoguanidine)
C: adtn hydrobromide (aka adtn)
D: galanthamine (aka galantamine)
E: aspartic acid, hydrobromide (aka aspartic acid)
F: None of the above. | D |
<Instruct>: Given the context 'Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage.', select the correct biomedical concept corresponding to 'scopolamine'. Answer using one of the provided options. | <Options>: A: scopolamine derivatives
B: scopoletin
C: transderm scop (aka scopolamine)
D: hyoscine n-oxide
E: scopathricin
F: None of the above. | C |
<Instruct>: Given the context 'Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage.', select the correct biomedical concept corresponding to 'hyoscine'. Answer using one of the provided options. | <Options>: A: epimeloscine (aka meloscine)
B: scopace (aka scopolamine)
C: scopolamines (aka scopolamine derivatives)
D: hyoscine n-butylbromide (aka butylscopolammonium bromide)
E: hyoscine methiodide (aka n-methylscopolamine)
F: None of the above. | B |
<Instruct>: Given the context 'It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block.', select the correct biomedical concept corresponding to 'physostigmine'. Answer using one of the provided options. | <Options>: A: synstigmin (aka neostigmine)
B: physostigmine
C: pyridostigmine (aka pyridostigmine bromide)
D: physostigmine salicylate
E: quilostigmine
F: None of the above. | B |
<Instruct>: Given the context 'However, studies into the dose necessary to combating scopolamine intoxication are indicated.', select the correct biomedical concept corresponding to 'scopolamine'. Answer using one of the provided options. | <Options>: A: scopolamine hydrobromide (aka scopolamine)
B: methiodide, hyoscine (aka n-methylscopolamine)
C: scopolin
D: diacetyl scopadol (aka diacetylscopadol)
E: scopoletin
F: None of the above. | A |
<Instruct>: Given the context 'Effects of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium compounds
B: lithium-4
C: lithium-7 (aka lithium)
D: lithium-3
E: lithium-11
F: None of the above. | C |
<Instruct>: Given the context 'Rats with lithium-induced nephropathy were subjected to high protein (HP) feeding, uninephrectomy (NX) or a combination of these, in an attempt to induce glomerular hyperfiltration and further progression of renal failure.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: liotrix (aka thyroxine, triiodothyronine drug combination)
B: lithium 7 (aka lithium)
C: lithium carbonate
D: lithium gaba (aka gamma-aminobutyric acid)
E: lithium-11
F: None of the above. | B |
<Instruct>: Given the context 'Rats with lithium-induced nephropathy were subjected to high protein (HP) feeding, uninephrectomy (NX) or a combination of these, in an attempt to induce glomerular hyperfiltration and further progression of renal failure.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium sulfide
B: lithium gaba (aka gamma-aminobutyric acid)
C: lithium-9
D: lithium-4
E: liotrix (aka thyroxine, triiodothyronine drug combination)
F: None of the above. | F |
<Instruct>: Given the context 'Newborn female Wistar rats were fed a lithium-containing diet (50 mmol/kg) for 8 weeks and then randomized to normal diet, HP diet (40 vs. 19%), NX or HP+NX for another 8 weeks.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium-11
B: lithium citrate
C: lithium-4
D: lithium sulfide
E: lithium 7 (aka lithium)
F: None of the above. | E |
<Instruct>: Given the context 'Corresponding non-lithium pretreated groups were generated.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium gaba (aka gamma-aminobutyric acid)
B: lithium gluconate (aka gluconic acid)
C: lithium
D: carbonate, lithium (aka lithium carbonate)
E: lithium sulfide
F: None of the above. | C |
<Instruct>: Given the context 'When comparing all lithium treated versus non-lithium-treated groups, lithium caused a reduction in glomerular filtration rate (GFR) without significant changes in effective renal plasma flow (as determined by a marker secreted into the proximal tubules) or lithium clearance.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium citrate
B: lithium sulfide
C: lithium-9
D: liotrix (aka thyroxine, triiodothyronine drug combination)
E: lithium 7 (aka lithium)
F: None of the above. | E |
<Instruct>: Given the context 'When comparing all lithium treated versus non-lithium-treated groups, lithium caused a reduction in glomerular filtration rate (GFR) without significant changes in effective renal plasma flow (as determined by a marker secreted into the proximal tubules) or lithium clearance.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: compounds, lithium (aka lithium compounds)
B: lithium-3
C: lithium
D: lithium gaba (aka gamma-aminobutyric acid)
E: lithium-4
F: None of the above. | C |
<Instruct>: Given the context 'When comparing all lithium treated versus non-lithium-treated groups, lithium caused a reduction in glomerular filtration rate (GFR) without significant changes in effective renal plasma flow (as determined by a marker secreted into the proximal tubules) or lithium clearance.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium gluconate (aka gluconic acid)
B: bicarbonate, lithium (aka lithium carbonate)
C: lithium 7 (aka lithium)
D: lithium gaba (aka gamma-aminobutyric acid)
E: compounds, lithium (aka lithium compounds)
F: None of the above. | C |
<Instruct>: Given the context 'When comparing all lithium treated versus non-lithium-treated groups, lithium caused a reduction in glomerular filtration rate (GFR) without significant changes in effective renal plasma flow (as determined by a marker secreted into the proximal tubules) or lithium clearance.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: liotrix (aka thyroxine, triiodothyronine drug combination)
B: lithium
C: lithium gluconate (aka gluconic acid)
D: compounds, lithium (aka lithium compounds)
E: lithium chloride (licl) (aka lithium chloride)
F: None of the above. | B |
<Instruct>: Given the context 'Consequently, lithium pretreatment caused a fall in filtration fraction and an increase in fractional Li excretion.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: lithium chloride
B: liotrix (aka thyroxine, triiodothyronine drug combination)
C: lithium-7 (aka lithium)
D: lithium sulfide
E: lithium gluconate (aka gluconic acid)
F: None of the above. | C |
<Instruct>: Given the context 'Consequently, lithium pretreatment caused a fall in filtration fraction and an increase in fractional Li excretion.', select the correct biomedical concept corresponding to 'li'. Answer using one of the provided options. | <Options>: A: thallium
B: lithium 7 (aka lithium)
C: lithium-11
D: liyan
E: lithium-3
F: None of the above. | B |
<Instruct>: Given the context 'Lithium also caused proteinuria and systolic hypertension in absence of glomerulosclerosis.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: liotrix (aka thyroxine, triiodothyronine drug combination)
B: lithium-3
C: lithium-7 (aka lithium)
D: compounds, lithium (aka lithium compounds)
E: lithium carbonate
F: None of the above. | C |
<Instruct>: Given the context 'HP failed to accentuante progression of renal failure and in fact tended to increase GFR and decrease plasma creatinine levels in lithium pretreated rats.', select the correct biomedical concept corresponding to 'creatinine'. Answer using one of the provided options. | <Options>: A: carnitine
B: 5,7-dihydroxytryptamine creatinine
C: creatol
D: sulfate salt, creatinine (aka creatinine)
E: creatine
F: None of the above. | D |
<Instruct>: Given the context 'HP failed to accentuante progression of renal failure and in fact tended to increase GFR and decrease plasma creatinine levels in lithium pretreated rats.', select the correct biomedical concept corresponding to 'creatinine'. Answer using one of the provided options. | <Options>: A: creatol
B: citral
C: creatine
D: epoxycreatine
E: chromium carbonyl (aka chromium hexacarbonyl)
F: None of the above. | F |
<Instruct>: Given the context 'HP failed to accentuante progression of renal failure and in fact tended to increase GFR and decrease plasma creatinine levels in lithium pretreated rats.', select the correct biomedical concept corresponding to 'lithium'. Answer using one of the provided options. | <Options>: A: compounds, lithium (aka lithium compounds)
B: lithium citrate
C: lithium 7 (aka lithium)
D: liotrix (aka thyroxine, triiodothyronine drug combination)
E: lithium-3
F: None of the above. | C |
<Instruct>: Given the context 'NX+HP caused a further rise in blood pressure in Li-pretreated rats.', select the correct biomedical concept corresponding to 'li'. Answer using one of the provided options. | <Options>: A: lithium chloride (licl) (aka lithium chloride)
B: lithium-7 (aka lithium)
C: lithium compounds
D: lithium citrate
E: lithium-4
F: None of the above. | B |
<Instruct>: Given the context 'The results indicate that Li-induced nephropathy, even when the GFR is only modestly reduced, is associated with proteinuria and arterial systolic hypertension.', select the correct biomedical concept corresponding to 'li'. Answer using one of the provided options. | <Options>: A: liyan
B: lithium 7 (aka lithium)
C: lithium chloride (licl) (aka lithium chloride)
D: lithium-11
E: thallium
F: None of the above. | B |
<Instruct>: Given the context 'Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: acid, fusaric (aka fusaric acid)
B: fumaric acid
C: fusaricidin a
D: fusaminic acid
E: acid, fusidic (aka fusidic acid)
F: None of the above. | E |
<Instruct>: Given the context 'Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin.', select the correct biomedical concept corresponding to 'cyclosporin'. Answer using one of the provided options. | <Options>: A: cyclosporin-like substance
B: cyclosporines (aka cyclosporins)
C: cyclosporin f
D: cyclosporin c
E: cyclosporine a (aka cyclosporine)
F: None of the above. | E |
<Instruct>: Given the context 'Fusidic acid is an antibiotic with T-cell specific immunosuppressive effects similar to those of cyclosporin.', select the correct biomedical concept corresponding to 'cyclosporin'. Answer using one of the provided options. | <Options>: A: cyclosporin lactam(3,4)
B: cyclosporine a (aka cyclosporine)
C: cyclosporin d
D: cyclosporine h (aka cyclosporin h)
E: cyclosporins
F: None of the above. | B |
<Instruct>: Given the context 'Because of the need for the development of new treatments for Crohn's disease, a pilot study was undertaken to estimate the pharmacodynamics and tolerability of fusidic acid treatment in chronic active, therapy-resistant patients.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: fusaricide
B: fusidic acid, sodium salt (aka fusidic acid)
C: fuscin
D: fusaric acid
E: flavaspidic acid
F: None of the above. | B |
<Instruct>: Given the context 'Fusidic acid was administered orally in a dose of 500 mg t.d.s.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: fusaric acid
B: fuscine
C: flavaspidic acid
D: piscidic acid
E: fusidic acid
F: None of the above. | E |
<Instruct>: Given the context 'Five of 8 patients (63%) improved during fusidic acid treatment: 3 at two weeks and 2 after four weeks.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: acid, fusidic (aka fusidic acid)
B: fusaricidin a
C: fumaric acid
D: fuscin
E: fusaric acid
F: None of the above. | A |
<Instruct>: Given the context 'The results of this pilot study suggest that fusidic acid may be of benefit in selected chronic active Crohn's disease patients in whom conventional treatment is ineffective.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: piscidic acid
B: fumaric acid
C: fusarinolic acid
D: flavaspidic acid
E: fusidin (aka fusidic acid)
F: None of the above. | E |
<Instruct>: Given the context 'The results of this pilot study suggest that fusidic acid may be of benefit in selected chronic active Crohn's disease patients in whom conventional treatment is ineffective.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: flavaspidic acid
B: fusaricidin a
C: tetrahydrofuroic acid (aka tetrahydro-2-furancarboxylic acid)
D: fusaricide
E: (s)-(+)-fusarinolic acid (aka fusarinolic acid)
F: None of the above. | F |
<Instruct>: Given the context 'Because there seems to exist a scientific rationale for the use of fusidic acid at the cytokine level in inflammatory bowel disease, we suggest that the role of this treatment should be further investigated.', select the correct biomedical concept corresponding to 'fusidic acid'. Answer using one of the provided options. | <Options>: A: fusidin (aka fusidic acid)
B: fuscine
C: fusaricidin a
D: fusicoccin-a (aka fusicoccin)
E: fumaric acid
F: None of the above. | A |
<Instruct>: Given the context 'Electrocardiographic evidence of myocardial injury in psychiatrically hospitalized cocaine abusers.', select the correct biomedical concept corresponding to 'cocaine'. Answer using one of the provided options. | <Options>: A: carbocaine (aka mepivacaine)
B: cafilon
C: hcl, cocaine (aka cocaine)
D: carnitine
E: catecholamphetamine (aka alpha-methyldopamine)
F: None of the above. | C |
<Instruct>: Given the context 'The electrocardiograms (ECG) of 99 cocaine-abusing patients were compared with the ECGs of 50 schizophrenic controls.', select the correct biomedical concept corresponding to 'cocaine'. Answer using one of the provided options. | <Options>: A: cocaine
B: carnitine
C: cocobetaine
D: cocaine methiodide
E: cathinone
F: None of the above. | A |
<Instruct>: Given the context 'Eleven of the cocaine abusers and none of the controls had ECG evidence of significant myocardial injury defined as myocardial infarction, ischemia, and bundle branch block.', select the correct biomedical concept corresponding to 'cocaine'. Answer using one of the provided options. | <Options>: A: carbocaïne (aka mepivacaine)
B: carnitine
C: cocaine hcl (aka cocaine)
D: cafilon
E: cocaine benzoyl thioester
F: None of the above. | C |
<Instruct>: Given the context 'Sulpiride-induced tardive dystonia.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: suleparoid
B: sulpor (aka sulpiride)
C: sulproston (aka sulprostone)
D: sulisatin
E: sulperazone
F: None of the above. | B |
<Instruct>: Given the context 'Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: sulpyrin (aka dipyrone)
B: sulisatin
C: suleparoid
D: sulperazon (aka sulperazone)
E: sulp (aka sulpiride)
F: None of the above. | E |
<Instruct>: Given the context 'Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties.', select the correct biomedical concept corresponding to 'antidepressant'. Answer using one of the provided options. | <Options>: A: antipsychotic drug (aka antipsychotic agents)
B: antidementia agents (aka nootropic agents)
C: appetite depressant (aka appetite depressants)
D: atypical antidepressants (aka antidepressive agents, second-generation)
E: antidepressants (aka antidepressive agents)
F: None of the above. | E |
<Instruct>: Given the context 'Although initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: sulp (aka sulpiride)
B: suleparoid
C: sulisatin
D: sultopride hydrochloride (aka amisulpride)
E: sulnate
F: None of the above. | A |
<Instruct>: Given the context 'We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: sulpiride
B: sulprim (aka trimethoprim, sulfamethoxazole drug combination)
C: amisulpride
D: sulproston (aka sulprostone)
E: suleparoid
F: None of the above. | A |
<Instruct>: Given the context 'We could not find any previous reports of sulpiride-induced tardive dystonia.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: sulprim (aka trimethoprim, sulfamethoxazole drug combination)
B: sulisatin
C: suleparoid
D: 3-sulfonyl-1h-pyrrole
E: sulpor (aka sulpiride)
F: None of the above. | E |
<Instruct>: Given the context 'We could not find any previous reports of sulpiride-induced tardive dystonia.', select the correct biomedical concept corresponding to 'sulpiride'. Answer using one of the provided options. | <Options>: A: suleparoid
B: sulnate
C: sulproston (aka sulprostone)
D: 3-sulfonyl-1h-pyrrole
E: sulisatin
F: None of the above. | F |
<Instruct>: Given the context 'Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.', select the correct biomedical concept corresponding to 'desferrioxamine'. Answer using one of the provided options. | <Options>: A: n-hydroxy-desferrioxamine b (aka n-hydroxydesferrioxamine b)
B: deferoxamine
C: deferrioxamine e
D: desferriferrithiocin
E: zinc-desferrioxamine
F: None of the above. | B |
<Instruct>: Given the context 'During an 18-month period of study 41 hemodialyzed patients receiving desferrioxamine (10-40 mg/kg BW/3 times weekly) for the first time were monitored for detection of audiovisual toxicity.', select the correct biomedical concept corresponding to 'desferrioxamine'. Answer using one of the provided options. | <Options>: A: aluminum-desferrioxamine complex (aka aluminoxamine)
B: n-hydroxy-desferrioxamine b (aka n-hydroxydesferrioxamine b)
C: desferrioxamine e
D: desferrithiocin
E: desferrioxamine (aka deferoxamine)
F: None of the above. | E |
<Instruct>: Given the context 'Desferrioxamine withdrawal resulted in a complete recovery of visual function in 1 patient and partial recovery in 3, and a complete reversal of hearing loss in 3 patients and partial recovery in 3.', select the correct biomedical concept corresponding to 'desferrioxamine'. Answer using one of the provided options. | <Options>: A: desferroxamine (aka deferoxamine)
B: zinc-desferrioxamine
C: aluminum-desferrioxamine complex (aka aluminoxamine)
D: deferrioxamine e
E: mangan-desferrioxamin
F: None of the above. | A |
<Instruct>: Given the context 'This toxicity appeared in patients receiving the higher doses of desferrioxamine or coincided with the normalization of ferritin or aluminium serum levels.', select the correct biomedical concept corresponding to 'desferrioxamine'. Answer using one of the provided options. | <Options>: A: desferrioxamine b (aka deferoxamine)
B: aluminum-desferrioxamine complex (aka aluminoxamine)
C: manganese desferioxamine
D: zinc-desferrioxamine
E: desferriferrithiocin
F: None of the above. | A |
<Instruct>: Given the context 'The data indicate that audiovisual toxicity is not an infrequent complication in hemodialyzed patients receiving desferrioxamine.', select the correct biomedical concept corresponding to 'desferrioxamine'. Answer using one of the provided options. | <Options>: A: desferioximine (aka deferoxamine)
B: ferroxamine (aka ferrioxamine b)
C: cu(ii)-desferrioxamine (aka copper-desferal complex)
D: mangan-desferrioxamin
E: manganese desferrioxamine (aka manganese desferioxamine)
F: None of the above. | A |
<Instruct>: Given the context 'Myasthenia gravis presenting as weakness after magnesium administration.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: magnesium compounds
B: magnesium bromide
C: magnesium
D: magmed (aka magaldrate)
E: magnesium phosphate
F: None of the above. | C |
<Instruct>: Given the context 'We studied a patient with no prior history of neuromuscular disease who became virtually quadriplegic after parenteral magnesium administration for preeclampsia.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: magnesium bromide
B: magnesium
C: magmed (aka magaldrate)
D: magnesium phosphate
E: magnesium chloride (mgcl2) (aka magnesium chloride)
F: None of the above. | B |
<Instruct>: Given the context 'The serum magnesium concentration was 3.0 mEq/L, which is usually well tolerated.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: magnesium oxide
B: magnesium compounds
C: magnesium nitrate
D: magnesium
E: magmed (aka magaldrate)
F: None of the above. | D |
<Instruct>: Given the context 'The magnesium was stopped and she recovered over a few days.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: magnesium
B: magnesium nitrate
C: chloride, magnesium (aka magnesium chloride)
D: aspartate, magnesium (aka aspartic acid)
E: magnesium phosphate
F: None of the above. | A |
<Instruct>: Given the context 'Her acetylcholine receptor antibody level was markedly elevated.', select the correct biomedical concept corresponding to 'acetylcholine'. Answer using one of the provided options. | <Options>: A: acetylcholine agents (aka cholinergic agents)
B: acetyl carnitine (aka acetylcarnitine)
C: choline
D: acetylcholine
E: aminocholine
F: None of the above. | D |
<Instruct>: Given the context 'Her acetylcholine receptor antibody level was markedly elevated.', select the correct biomedical concept corresponding to 'acetylcholine'. Answer using one of the provided options. | <Options>: A: aminocholine
B: choline
C: acetylhomocholine
D: agonists, acetylcholine (aka cholinergic agonists)
E: acetylethylcholine (aka acetylmonoethylcholine)
F: None of the above. | F |
<Instruct>: Given the context 'Although paralysis after magnesium administration has been described in patients with known myasthenia gravis, it has not previously been reported to be the initial or only manifestation of the disease.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: manganese
B: magnesium
C: magnesium-25
D: compounds, magnesium (aka magnesium compounds)
E: magnesium-30
F: None of the above. | B |
<Instruct>: Given the context 'Patients who are unusually sensitive to the neuromuscular effects of magnesium should be suspected of having an underlying disorder of neuromuscular transmission.', select the correct biomedical concept corresponding to 'magnesium'. Answer using one of the provided options. | <Options>: A: magnesium
B: compounds, magnesium (aka magnesium compounds)
C: aspartate, magnesium (aka aspartic acid)
D: magnesium nitrate
E: chloride, magnesium (aka magnesium chloride)
F: None of the above. | A |
<Instruct>: Given the context 'Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide.', select the correct biomedical concept corresponding to 'chloroacetaldehyde'. Answer using one of the provided options. | <Options>: A: 2-chloroacetal
B: acetylformaldehyde (aka pyruvaldehyde)
C: chloroacetonitrile
D: 2-aminoacetaldehyde
E: 2-chloroacetaldehyde (aka chloroacetaldehyde)
F: None of the above. | E |
<Instruct>: Given the context 'Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide.', select the correct biomedical concept corresponding to 'cyclophosphamide'. Answer using one of the provided options. | <Options>: A: cyclophosphamide-mustard (aka aldophosphamide)
B: cytoxan (aka cyclophosphamide)
C: cytosinine
D: d4-cyclophosphamide
E: iminocyclophosphamide (aka iminophosphamide)
F: None of the above. | B |
<Instruct>: Given the context 'Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide.', select the correct biomedical concept corresponding to 'ifosfamide'. Answer using one of the provided options. | <Options>: A: glucosyl-ifosfamide mustard (aka beta-d-glucosylisophosphoramide mustard)
B: isofon
C: iphosphamide (aka ifosfamide)
D: ifosfamide bromide mustard (aka isophosphamide bromide mustard)
E: 2h-1,3,2-oxazaphosphorin-2-amine, n,n-bis(2-chloroethyl)-5,6-dihydro-, 2-oxide (aka iminophosphamide)
F: None of the above. | C |
<Instruct>: Given the context 'Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatics, an experimental study was carried out in order to elucidate the role of CAA in the development of hemorrhagic cystitis.', select the correct biomedical concept corresponding to 'chloroacetaldehyde'. Answer using one of the provided options. | <Options>: A: acraldehyde (aka acrolein)
B: 3-chloro-anisaldehyde (aka 3-chloroanisaldehyde)
C: chloracetone (aka chloroacetone)
D: chloroacetaldehyde hydrate (aka chloroacetaldehyde)
E: hydroxyacetaldehyde (aka glycolaldehyde)
F: None of the above. | D |
<Instruct>: Given the context 'Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatics, an experimental study was carried out in order to elucidate the role of CAA in the development of hemorrhagic cystitis.', select the correct biomedical concept corresponding to 'caa'. Answer using one of the provided options. | <Options>: A: aceric acid (aka 3-c-carboxy-5-deoxyxylose)
B: cma amino acid (aka n(omega)-carboxymethylarginine)
C: aminocaproic acids (aka aminocaproates)
D: aminocaproic acid
E: caa cyanoacetoacetamide cpd (aka n-(4-(4-tert-butylphenyl)thiazol-2-yl)-n-propyl-2-cyano-3-hydroxy-2-butenamide)
F: None of the above. | F |
<Instruct>: Given the context 'Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatics, an experimental study was carried out in order to elucidate the role of CAA in the development of hemorrhagic cystitis.', select the correct biomedical concept corresponding to 'caa'. Answer using one of the provided options. | <Options>: A: 3-acetylaminocarnitine
B: n-acetylalanine
C: aminocaproic acid
D: aminocaproic acids (aka aminocaproates)
E: acetylcarnitine
F: None of the above. | F |
<Instruct>: Given the context 'The data demonstrate that CAA after i.v. administration does not contribute to bladder damage.', select the correct biomedical concept corresponding to 'caa'. Answer using one of the provided options. | <Options>: A: n-acetylalanine
B: cyanoacetic acid
C: aceric acid (aka 3-c-carboxy-5-deoxyxylose)
D: aminocarnitine (aka emeriamine)
E: casamino acids
F: None of the above. | F |
<Instruct>: Given the context 'When instilled directly into the bladder, CAA exerts urotoxic effects, it is, however, susceptible to detoxification with mesna.', select the correct biomedical concept corresponding to 'caa'. Answer using one of the provided options. | <Options>: A: 3-acetylaminocarnitine
B: alpha-aminoacrylate (aka dehydroalanine)
C: cma amino acid (aka n(omega)-carboxymethylarginine)
D: acetoacetic acid
E: aminoacetonitrile
F: None of the above. | F |
<Instruct>: Given the context 'When instilled directly into the bladder, CAA exerts urotoxic effects, it is, however, susceptible to detoxification with mesna.', select the correct biomedical concept corresponding to 'caa'. Answer using one of the provided options. | <Options>: A: alpha-aminoacrylate (aka dehydroalanine)
B: n-acetylalanine
C: carboxycarbonyl-aminoalanine (aka oxalyldiaminopropionic acid)
D: 3-acetylaminocarnitine
E: aminocaproic acid
F: None of the above. | F |
<Instruct>: Given the context 'When instilled directly into the bladder, CAA exerts urotoxic effects, it is, however, susceptible to detoxification with mesna.', select the correct biomedical concept corresponding to 'mesna'. Answer using one of the provided options. | <Options>: A: sodium 2-mercaptoethanesulphonate (aka mesna)
B: ethyl mesilate (aka ethyl methanesulfonate)
C: methyl mesilate (aka methyl methanesulfonate)
D: mes cpd (aka mono-2-(methacryloyloxy)ethyl succinate)
E: mes compound (aka 2-(n-morpholino)ethanesulfonic acid)
F: None of the above. | A |
<Instruct>: Given the context 'Twenty common migraine patients received a one sided frontotemporal application of nitroglycerin (10 patients) or placebo ointment (10 patients) in a double blind study.', select the correct biomedical concept corresponding to 'nitroglycerin'. Answer using one of the provided options. | <Options>: A: glycerin-1-nitrate (aka glycerol-1-nitrate)
B: 1,2-glyceryl dinitrate (aka dinitroglycerol)
C: trinitrate, glyceryl (aka nitroglycerin)
D: trinonanoin (aka tripelargonin)
E: nitrogranulogen (aka mechlorethamine)
F: None of the above. | C |
<Instruct>: Given the context 'Early onset migraine attacks were induced by nitroglycerin in seven out of 10 patients versus no patient in the placebo group.', select the correct biomedical concept corresponding to 'nitroglycerin'. Answer using one of the provided options. | <Options>: A: 1,2-glyceryl dinitrate (aka dinitroglycerol)
B: trinonanoin (aka tripelargonin)
C: triethanolamine trinitrate (aka trolnitrate)
D: nitroglycol (aka ethylene glycol dinitrate)
E: 1,2,3-propanetriol, trinitrate (aka nitroglycerin)
F: None of the above. | E |
<Instruct>: Given the context 'Subsequently 20 migraine patients, who developed an early onset attack with frontotemporal nitroglycerin, received the drug in a second induction test at other body areas.', select the correct biomedical concept corresponding to 'nitroglycerin'. Answer using one of the provided options. | <Options>: A: triethanolamine trinitrate (aka trolnitrate)
B: nitroglyn (aka nitroglycerin)
C: trinonanoin (aka tripelargonin)
D: nitroglycol (aka ethylene glycol dinitrate)
E: glycerin-1-nitrate (aka glycerol-1-nitrate)
F: None of the above. | B |
<Instruct>: Given the context 'Thus the migraine-inducing effect of nitroglycerin seems to depend on direct stimulation of the habitual site of pain, suggesting that the frontotemporal region is of crucial importance in the development of a migraine crisis.', select the correct biomedical concept corresponding to 'nitroglycerin'. Answer using one of the provided options. | <Options>: A: trinitrin (aka nitroglycerin)
B: nitrogranulogen (aka mechlorethamine)
C: glyceryl dinitrate (aka dinitroglycerol)
D: trinonanoin (aka tripelargonin)
E: triethanolamine trinitrate (aka trolnitrate)
F: None of the above. | A |
<Instruct>: Given the context 'Clotiazepam-induced acute hepatitis.', select the correct biomedical concept corresponding to 'clotiazepam'. Answer using one of the provided options. | <Options>: A: 2h-thieno(2,3-e)-1,4-diazepin-2-one, 5-(2-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl- (aka clotiazepam)
B: n-desmethylmetaclazepam
C: clazepam
D: gen temazepam (aka temazepam)
E: nordiazepam (aka nordazepam)
F: None of the above. | A |
<Instruct>: Given the context 'We report the case of a patient who developed acute hepatitis with extensive hepatocellular necrosis, 7 months after the onset of administration of clotiazepam, a thienodiazepine derivative.', select the correct biomedical concept corresponding to 'clotiazepam'. Answer using one of the provided options. | <Options>: A: 2h-thieno(2,3-e)-1,4-diazepin-2-one, 5-(2-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl- (aka clotiazepam)
B: chlordiazepam (aka 4'-chlorodiazepam)
C: n-desmethyladinozolam (aka mono-n-demethyladinazolam)
D: nordiazepam (aka nordazepam)
E: camazepam
F: None of the above. | A |
<Instruct>: Given the context 'We report the case of a patient who developed acute hepatitis with extensive hepatocellular necrosis, 7 months after the onset of administration of clotiazepam, a thienodiazepine derivative.', select the correct biomedical concept corresponding to 'thienodiazepine'. Answer using one of the provided options. | <Options>: A: thienopyrrole
B: pyridyldithioethylamine
C: thienodiltiazem (aka 4-(2-dimethylaminoethyl)-4,5,6,7-tetrahydro-7-(4-methoxyphenyl)-5-oxothieno(2,3-b)(1,4)thiazepin-6-yl acetate)
D: 3,4-dihydro-1h-thieno(3,2-e)(1,4)diazepine-2,5-dione
E: thienodiazepine substance
F: None of the above. | E |
<Instruct>: Given the context 'Clotiazepam withdrawal was followed by prompt recovery.', select the correct biomedical concept corresponding to 'clotiazepam'. Answer using one of the provided options. | <Options>: A: chlordiazepam (aka 4'-chlorodiazepam)
B: clotiazepam
C: desmethylmedazepam
D: n-desmethyladinozolam (aka mono-n-demethyladinazolam)
E: desmethylclobazam
F: None of the above. | B |
<Instruct>: Given the context 'The administration of several benzodiazepines, chemically related to clotiazepam, did not interfere with recovery and did not induce any relapse of hepatitis.', select the correct biomedical concept corresponding to 'benzodiazepines'. Answer using one of the provided options. | <Options>: A: diebs (aka bis(2-(n-phenylcarboxamido)phenyl)diselenide)
B: 1,2-diazabenzene (aka pyridazine)
C: benzo(1,4)diazepin-2-one
D: triazolo(4,3-d)benzodiazepine
E: benzodiazepine (aka benzodiazepines)
F: None of the above. | E |
<Instruct>: Given the context 'The administration of several benzodiazepines, chemically related to clotiazepam, did not interfere with recovery and did not induce any relapse of hepatitis.', select the correct biomedical concept corresponding to 'benzodiazepines'. Answer using one of the provided options. | <Options>: A: triazolo(4,3-d)benzodiazepine
B: benzodiazepinones
C: benzodioxolylbutanamine (aka 1-(benzo(d)(1,3)dioxol-5-yl)butan-2-amine)
D: 1,4-benzodiazepine (aka bz-423)
E: 1,2-diazabenzene (aka pyridazine)
F: None of the above. | F |
<Instruct>: Given the context 'The administration of several benzodiazepines, chemically related to clotiazepam, did not interfere with recovery and did not induce any relapse of hepatitis.', select the correct biomedical concept corresponding to 'clotiazepam'. Answer using one of the provided options. | <Options>: A: clotiazepam
B: clazepam
C: temazepam
D: camazepam
E: n-desmethylmetaclazepam
F: None of the above. | A |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 16